• Home
  • Agric
  • Sci & Tech
  • Health
  • Environment
  • Hausa News
  • More
    • Business/Banking & Finance
    • POLITICS
    • Entertainments & Sports
    • International
    • Investigation
    • Law & Human Rights
    • Africa
    • ACCOUNTABILITY/CORRUPTION
    • Hassan Gimba
    • Column
    • Prof. Jibrin Ibrahim
    • Prof. M.K. Othman
    • Defense/Security
    • Education
    • Energy/Electricity
    • Entertainment/Arts & Sports
    • Society and Lifestyle
    • Food & Agriculture
    • Health & Healthy Living
    • International News
    • Interviews
    • Investigation/Fact-Check
    • LAW & HUMAN RIGHTS
    • Oil & Gas/Mineral Resources
    • PRESS FREEDOM/JOURNALISM/PR
    • General News
    • Presidency
  • About Us
    • Contact Us
    • Board Of Advisory
    • Privacy Policy
    • Ethics Policy
    • Teamwork And Collaboration Policy
    • Fact-Checking Policy
    • Advertising
  • Media OutReach Newswire
    • Wire News
  • The Stories
Facebook Twitter Instagram
Trending
  • Ghana warns of El Niño-linked health risks as harmattan intensifies
  • Ghana’s UCC Vice-Chancellor meets 12-year-old student, urges focus on excellence
  • IAR, NBMA train stakeholders on managing low-level presence of GM crops
  • PAN Kano plans accreditation for poultry input distributors
  • Health council backs new policies on telemedicine, E-pharmacy
  • Nigeria needs domestic funding for family planning, experts say
  • Smallholders unable to afford essential farm inputs, expert says
  • Farmers say high costs drive up catfish prices
Facebook Twitter Instagram YouTube
AsheNewsAsheNews
  • Home
  • Agric

    IAR, NBMA train stakeholders on managing low-level presence of GM crops

    November 20, 2026

    PAN Kano plans accreditation for poultry input distributors

    November 20, 2026

    Smallholders unable to afford essential farm inputs, expert says

    November 19, 2026

    Farmers say high costs drive up catfish prices

    November 19, 2026

    Rising feed costs push farmers out of business

    November 19, 2026
  • Sci & Tech

    IAR, NBMA train stakeholders on managing low-level presence of GM crops

    November 20, 2026

    Sultan inaugurates 500-seat ICT centre at Saki nursing college, backs health technology expansion

    November 19, 2026

    Linking payment systems key to Africa’s trade integration, officials say

    November 19, 2026

    CJID announces 2026 media, development conference

    November 18, 2026

    GOVMAIL adoption grows across Nigeria’s public sector

    November 17, 2026
  • Health

    Health council backs new policies on telemedicine, E-pharmacy

    November 20, 2026

    Nigeria needs domestic funding for family planning, experts say

    November 20, 2026

    Foundation, ACF urge investment in boys’ development

    November 19, 2026

    Nigeria’s home care framework launched to support vulnerable people

    November 19, 2026

    WHO calls for coordinated action to curb antimicrobial resistance

    November 19, 2026
  • Environment

    Ghana warns of El Niño-linked health risks as harmattan intensifies

    November 20, 2026

    Ghana’s UCC Vice-Chancellor meets 12-year-old student, urges focus on excellence

    November 20, 2026

    NEWSAN calls for urgent repairs to sewage systems

    November 19, 2026

    Nigeria targets open defecation free status by 2030

    November 19, 2026

    Erosion puts Cross River transmission line at risk

    November 19, 2026
  • Hausa News

    Foundation unveils public sector reform playbook

    November 12, 2026

    Tinubu asks Reps to approve N10.79tn external borrowing for 2026 budget

    November 11, 2026

    UNA signs MoU to launch air Bissau in Guinea-Bissau

    June 15, 2026

    Otti plans 250-room 5-star hotel in Umuahia

    April 11, 2026

    Anti-quackery task force seals 4 fake hospitals in Rivers

    August 29, 2025
  • More
    1. Business/Banking & Finance
    2. POLITICS
    3. Entertainments & Sports
    4. International
    5. Investigation
    6. Law & Human Rights
    7. Africa
    8. ACCOUNTABILITY/CORRUPTION
    9. Hassan Gimba
    10. Column
    11. Prof. Jibrin Ibrahim
    12. Prof. M.K. Othman
    13. Defense/Security
    14. Education
    15. Energy/Electricity
    16. Entertainment/Arts & Sports
    17. Society and Lifestyle
    18. Food & Agriculture
    19. Health & Healthy Living
    20. International News
    21. Interviews
    22. Investigation/Fact-Check
    23. LAW & HUMAN RIGHTS
    24. Oil & Gas/Mineral Resources
    25. PRESS FREEDOM/JOURNALISM/PR
    26. General News
    27. Presidency
    Featured
    Recent

    Ghana warns of El Niño-linked health risks as harmattan intensifies

    November 20, 2026

    Ghana’s UCC Vice-Chancellor meets 12-year-old student, urges focus on excellence

    November 20, 2026

    IAR, NBMA train stakeholders on managing low-level presence of GM crops

    November 20, 2026
  • About Us
    1. Contact Us
    2. Board Of Advisory
    3. Privacy Policy
    4. Ethics Policy
    5. Teamwork And Collaboration Policy
    6. Fact-Checking Policy
    7. Advertising
    Featured
    Recent

    Ghana warns of El Niño-linked health risks as harmattan intensifies

    November 20, 2026

    Ghana’s UCC Vice-Chancellor meets 12-year-old student, urges focus on excellence

    November 20, 2026

    IAR, NBMA train stakeholders on managing low-level presence of GM crops

    November 20, 2026
  • Media OutReach Newswire
    • Wire News
  • The Stories
AsheNewsAsheNews
Home»Health & Healthy Living»Ebola-infected monkeys cured with pill, raising hopes for humans – Study
Health & Healthy Living

Ebola-infected monkeys cured with pill, raising hopes for humans – Study

EditorBy EditorMarch 15, 2025Updated:March 15, 2025No Comments3 Mins Read
Ebola
Share
Facebook Twitter LinkedIn Pinterest Email

Monkeys infected with Ebola can be cured with a pill, according to a new study out Friday that could pave the way for more practical, affordable treatments in humans.

First identified in 1976 and thought to have crossed over from bats, Ebola is a deadly viral disease spread through direct contact with bodily fluids, causing severe bleeding and organ failure.

Because outbreaks primarily affect sub-Saharan Africa, pharmaceutical companies have lacked financial incentives to develop treatments, and the sporadic nature of outbreaks has made clinical trials difficult.

A vaccine was only widely approved in 2019, and while two intravenous antibody treatments improve outcomes, they require costly cold storage and are difficult to administer in some of the world’s poorest regions.

“We’re really trying to come up with something that was more practical, easier to use, that could be used to help prevent, control, and contain outbreaks,” Thomas Geisbert, a virologist at The University of Texas Medical Branch at Galveston, who led the new study published in Science Advances, told AFP.

For their experiment, Geisbert and colleagues tested the antiviral Obeldesivir, the oral form of intravenous Remdesivir, originally developed for Covid-19.

Obeldesivir is a “polymerase inhibitor,” meaning it blocks an enzyme crucial for viral replication.

The team infected rhesus and cynomolgus macaques with a high dose of the Makona variant of the Ebola virus.

A day after exposure, ten monkeys then received an Obeldesivir pill daily for ten days, while three control monkeys received no treatment and died.

Obeldesivir protected 80 percent of the cynomolgus macaques and 100 percent of the rhesus macaques, which are biologically closer to humans.

The drug not only cleared the virus from the treated monkeys’ blood but also triggered an immune response, helping them develop antibodies while avoiding organ damage.

Geisbert explained that while the number of monkeys was relatively small, the study was statistically powerful because they were exposed to an extraordinarily high dose of the virus — roughly 30,000 times the lethal dose for humans. This reduced the need for additional control monkeys, limiting unnecessary animal deaths.

The researcher, who has worked on Ebola since the 1980s and is credited with discovering the Reston strain, said one of the most exciting aspects of Obeldesivir is its “broad-spectrum” protection, compared to the approved antibody treatments that only work against the Zaire species of Ebola.

“That’s a huge advantage,” Geisbert said.

Pharmaceutical maker Gilead is currently advancing Obeldesivir to Phase 2 clinical trials for Marburg virus, a close relative of Ebola.

Geisbert also emphasized the importance of funding from the US National Institutes of Health, amid reports that dozens of grants have been canceled under President Donald Trump’s administration.

“All these drugs and vaccines that were developed against Ebola and a lot of these exotic viruses and pathogens — 90 percent of the money comes from the US government,” he said, adding, “I think the general public would agree we need treatments for Ebola.”

AFP

Channels TV

Ebola-infected monkeys Pills
Share. Facebook Twitter Pinterest LinkedIn WhatsApp Reddit Tumblr Email
Editor
  • Website

Related Posts

Health council backs new policies on telemedicine, E-pharmacy

November 20, 2026

Nigeria needs domestic funding for family planning, experts say

November 20, 2026

Foundation, ACF urge investment in boys’ development

November 19, 2026

Leave A Reply Cancel Reply

Ghana warns of El Niño-linked health risks as harmattan intensifies

November 20, 2026

Ghana’s UCC Vice-Chancellor meets 12-year-old student, urges focus on excellence

November 20, 2026

IAR, NBMA train stakeholders on managing low-level presence of GM crops

November 20, 2026

PAN Kano plans accreditation for poultry input distributors

November 20, 2026
About Us
About Us

ASHENEWS (AsheNewsDaily.com), published by PenPlus Online Media Publishers, is an independent online newspaper. We report development news, especially on Agriculture, Science, Health and Environment as they affect the under-reported rural and urban poor.

We also conduct investigations, especially in the areas of ASHE, as well as other general interests, including corruption, human rights, illicit financial flows, and politics.

Contact Info:
  • 1st floor, Dogon Daji House, No. 5, Maiduguri Road, Sokoto
  • +234(0)7031140009
  • ashenewsdaily@gmail.com
Facebook Twitter Instagram Pinterest
© 2026 All Rights Reserved. ASHENEWS Daily Designed & Managed By DeedsTech

Type above and press Enter to search. Press Esc to cancel.